Home Newsfeeds JP Morgan Maintains Overweight on Silvergate Capital, Lowers Price Target to $90

JP Morgan Maintains Overweight on Silvergate Capital, Lowers Price Target to $90

JP Morgan analyst Steven Alexopoulos maintains Silvergate Capital (NYSE:SI) with a Overweight and lowers the price target from $200 to $90.

byBenzinga Newsdesk

July 1, 2022

1 minute read

JP Morgan analyst Steven Alexopoulos maintains Silvergate Capital (NYSE:SI) with a Overweight and lowers the price target from $200 to $90.

Citigroup Maintains Buy on Schrodinger, Raises Price Target to $51

By Benzinga Newsdesk

January 31, 7:54 AM

Citigroup analyst David Lebowitz maintains Schrodinger (NASDAQ:SDGR) with a Buy and raises the price target from $48 to $51.

SDGR

Celestica Sees Q1 2023 EPS $0.41-$0.47 Vs $0.40 Est.; Q1 23 Revenue $1.725B-$1.875B Vs $1.72B Est.; FY23 EPS $1.95-$2.05 Vs $2.03 Est.; FY23 Revenue Of At Least $7.5B

By Happy Mohamed

January 26, 1:21 AM

First Quarter of 2023 (Q1 2023) Guidance Q1 2023 Guidance Revenue (in billions) $1.725 to $1.875 Non-IFRS

CLS

Christina Lake Cannabis Q2 Revenue Shows Strong Growth Both Sequentially And YoY, Here Are The Details

By Vuk Zdinjak

August 11, 9:27 AM

Christina Lake Cannabis Corp. (OTCQB: CLCFF) (CSE:CLC) revenue in Q2 2022 was CA$2.3 million ($1.8 million), a 40% increase over Q1

CLCFF

JPMorgan Challenges Class-Action Status For Jeffrey Epstein’s Accusers

By Bibhu Pattnaik

May 13, 3:14 PM

JPMorgan Chase & Co (NYSE: JPM) has appealed to a federal judge to reject a class-action status request by one of Jeffrey Epstein's accusers, who accused the bank of enabling the late

JPM

JP Morgan Maintains Overweight on Silvergate Capital, Lowers Price Target to $90

Related Posts

Citigroup Maintains Buy on Schrodinger, Raises Price Target to $51

Celestica Sees Q1 2023 EPS $0.41-$0.47 Vs $0.40 Est.; Q1 23 Revenue $1.725B-$1.875B Vs $1.72B Est.; FY23 EPS $1.95-$2.05 Vs $2.03 Est.; FY23 Revenue Of At Least $7.5B

Christina Lake Cannabis Q2 Revenue Shows Strong Growth Both Sequentially And YoY, Here Are The Details

JPMorgan Challenges Class-Action Status For Jeffrey Epstein’s Accusers